The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy
Hualin Xu, Jie Fu, Qiang Tu, Qingyun Shuai, Yizhi Chen, Fuyun Wu, Zheng Cao
Topics & Concepts
EmpagliflozinAutophagyMedicinePharmacologyBiologyDiabetes mellitusEndocrinologyType 2 diabetesApoptosisBiochemistryDiabetes Treatment and ManagementPancreatic function and diabetesAdenosine and Purinergic Signaling